Compare Medpace Holdings Inc (MEDP) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? Medpace Holdings Inc trades at $528.16 (market cap $15.18B), while ZIM Integrated Shipping Services Ltd trades at $25.02 (market cap $3.00B). The key difference: Medpace Holdings Inc is far larger — about 5.1× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | ZIM | |
|---|---|---|
Market Cap | $15.18B | $3.00B |
Sector | Technology | Industrials |
52-Week High | $620.59 | $29.27 |
52-Week Low | $393.42 | $12.44 |
Enterprise Value | $14.65B | $6.85B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% on the day, with a neutral technical signal and mixed oscillators. The stock shows strong profitability with a 17.19% net margin and 77.25% ROE, though valuations are elevated with a P/E of 33.22. Recent quarters have consistently beaten EPS estimates, but a class action lawsuit filed in June 2026 adds uncertainty. Revenue is projected to grow to $2.7B in 2026, while cash flow trends improve from negative to positive net cash flow.
The outlook is cautious due to high valuation and legal overhangs, but fundamental strength in earnings and backlog quality provides support. Analyst consensus is mixed with a $497 price target below current levels, indicating limited near-term upside. Key risks include lawsuit outcomes and competitive pressures in the CRO sector.
ZIM trades at $24.31, showing minimal daily movement. The stock faces a bearish technical outlook with mixed earnings, including a Q1 2026 miss. Financially, it maintains a strong cash position and low valuation multiples, but profitability has declined from 2025 to 2026. Recent news is dominated by merger uncertainty with Hapag-Lloyd and leadership changes.
The outlook is cautious due to regulatory risks around the merger and volatile shipping rates. Upside exists if the deal proceeds or freight markets tighten, but downside risk is significant if the merger fails, with analyst targets near $16.75. High cash burn and insider selling add to near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
